Biostar Microtech International (TPE:2399) Current Deferred Revenue: NT$0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:2399 Biostar Microtech International Corp TPE:2399
53 GF Score
Price NT$45.15
GF Value NT$17.26
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Biostar Microtech International Current Deferred Revenue?

Biostar Microtech International TPE:2399 -3.94% 53 Current Deferred Revenue is NT$0 Mil as of Mar. 2026. GuruFocus rates TPE:2399 with a GF Score™ of 53/100 and a GF Value™ of NT$17.26 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Biostar Microtech International's current deferred revenue for the quarter that ended in Mar. 2026 was NT$0 Mil.

Biostar Microtech International Current Deferred Revenue Related Terms

Biostar Microtech International Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Biostar Microtech International's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biostar Microtech International Current Deferred Revenue Chart

Biostar Microtech International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biostar Microtech International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TPE:2399
53GF Score
Biostar Microtech International Corp TPE:2399
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of NT$0 Mil mean?
Biostar Microtech International (TPE:2399) has a Current Deferred Revenue of NT$0 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Biostar Microtech International and its competitors.
Is Biostar Microtech International's Current Deferred Revenue too high?
Biostar Microtech International's current Current Deferred Revenue is NT$0 Mil. Overall, Biostar Microtech International has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biostar Microtech International's Current Deferred Revenue compare to DELL and ANET?
Biostar Microtech International's Current Deferred Revenue of NT$0 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Hardware company?
A good Current Deferred Revenue depends on the Hardware industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Biostar Microtech International and its competitors. Biostar Microtech International's current Current Deferred Revenue is NT$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biostar Microtech International stock overvalued right now?
Based on GuruFocus' analysis, Biostar Microtech International (TPE:2399) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$17.26, compared to a current price of NT$45.15 — trading 161.6% above its estimated fair value. The current Current Deferred Revenue is NT$0 Mil. Biostar Microtech International's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Biostar Microtech International (TPE:2399), the current Current Deferred Revenue is NT$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biostar Microtech International (TPE:2399) Overvalued in 2026?

Based on GuruFocus' analysis, Biostar Microtech International stock appears to be overvalued. The current stock price of NT$45.15 is trading 161.6% above its estimated GF Value™ of NT$17.26. GuruFocus considers Biostar Microtech International to be Significantly Overvalued.

Key valuation signals for TPE:2399:

  • Current Deferred Revenue: NT$0 Mil
  • GF Value™: NT$17.26 vs. price of NT$45.15 (161.6% above fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the TPE:2399 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biostar Microtech International Business Description

Address No. 108-2, Minquan Rd, 2nd Floor, Xindian District, New Taipei City, TWN
Biostar Microtech International Corp is engaged in the manufacturing and selling of computer motherboards, industrial computers, and other computer peripheral products. The company's offerings include Industrial computers, motherboards, graphics cards, solid-state drives, memory, and other Peripheral equipment. Its reportable segments are: i) Asia-Pacific Operating Segment: Manufacture of computer mainboards, industrial computers and display cards, and sale of electronic products in the Asia-Pacific area, ii) America Sales Segment: Sale of electronic products in the Americas, and iii) Europe Sales Segment: Sale of electronic products in Europe. The majority of the company's revenue is derived from the Asia-Pacific Operating Segment.
53GF Score

Get the complete analysis for TPE:2399

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$45.15
Price
NT$17.26
GF Value